Sidra Medicine in Qatar has announced the introduction of a revolutionary gene therapy for treating sickle cell anemia and thalassemia, marking a significant shift towards complete healing for the first time in the country.
A new study reveals that Etavopivat effectively reduces vaso-occlusive crises in patients with sickle cell anemia, marking a significant advancement in treating this complex health condition.
Recent medical research has announced the successful application of gene therapy for sickle cell anemia, representing a beacon of hope for patients. This achievement opens new horizons in the treatment of genetic disorders.